In the article “In Vivo Imaging of Amyloid Deposition in Alzheimer Disease Using the Radioligand 18F-AV-45 (Flobetapir F 18),” by Wong et al. (J Nucl Med. 2010;51:913–920), the main compound name is misspelled throughout. It should read florbetapir, not flobetapir. We regret the error.
The article “Diagnostic Value of 18F-FDG PET for Evaluation of Paraaortic Nodal Metastasis in Patients with Cervical Carcinoma: A Metaanalysis,” by Kang et al. (J Nucl Med. 2010;51:360–367), contains 2 data errors. In the first paragraph of the results, 6 (not 5) studies applied masking for interpretation of PET or PET/CT findings, and in the third paragraph of the discussion, false positivity (not positive posttest probability) ranged from 35% to 46% at the prevalence between 10% and 15% (not 20%). The authors regret the errors.
- © 2010 by Society of Nuclear Medicine
